Moreover, we show for the first time that a novel microbiota-derived metabolite, 12-KLCA, exhibits a powerful anti-inflammatory effect in DSS-induced colitis by increasing the VDR expression and decreasing the IL-17A secretion in colonic ILC3s. The gene discussed is VDR; the disease is colitis.